Doxofylline differs from methylxanthines in its movement of cytosolic calcium

This paper contributes to the pharmacological profile of doxofylline (Ansimar), a new xanthine derivative with high antibronchospastic activity and no extrapulmonary or cardiac side-effects, clearly demonstrating its inability to mobilize intracellular calcium stores, unlike other xanthines. In vitr...

Full description

Saved in:
Bibliographic Details
Published inInternational journal on tissue reactions Vol. 13; no. 3; p. 131
Main Authors Franzone, J S, Cirillo, R, Reboani, M C
Format Journal Article
LanguageEnglish
Published Switzerland 1991
Subjects
Aminophylline - pharmacology
Animals
Binding Sites
Blood Platelets - drug effects
Blood Platelets - metabolism
Calcium - blood
Calcium - metabolism
Cytosol - metabolism
Diltiazem - metabolism
Male
Muscle Contraction - drug effects
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - metabolism
Norepinephrine - pharmacology
Rabbits
Rats
Rats, Inbred Strains
Spectrometry, Fluorescence
Synaptosomes - drug effects
Synaptosomes - metabolism
Theophylline - analogs & derivatives
Theophylline - pharmacology
Verapamil - metabolism
Online AccessGet more information

Cover

More Information
Summary:This paper contributes to the pharmacological profile of doxofylline (Ansimar), a new xanthine derivative with high antibronchospastic activity and no extrapulmonary or cardiac side-effects, clearly demonstrating its inability to mobilize intracellular calcium stores, unlike other xanthines. In vitro, doxofylline does not cause rabbit ear artery contraction under Ca(++)-free conditions. In vivo, doxofylline does not induce a decrease in the calcium concentration of rabbit washed blood platelets. In the same trials theophylline showed opposite results. Furthermore, doxofylline does not antagonize receptors of Ca-antagonists, and does not interfere with the influx of calcium into the cell. Doxofylline also has a very low affinity for adenosine receptors inhibiting cAMP-phosphodiesterase as does theophylline. The absence of typical methylxanthine side-effects is undoubtedly due to doxofylline's low affinity for adenosine receptors, although this does not explain the absence of cardiovascular effects. The present study presents clear evidence that the inability of doxofylline to cause positive inotropism can be linked to its inability to induce calcium movement from intracellular stores.
ISSN:0250-0868